MRVI - Company ID 0001823239
The table below shows MARAVAI LIFESCIENCES HOLDINGS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $185.74M | $259.19M | $288.94M | $883.00M | $799.24M | $284.10M |
| Cost of revenue | $151.75M | $150.88M | $148.74M | $168.96M | $140.56M | $79.65M |
| Gross profit | $33.99M | $108.31M | $140.20M | - | - | - |
| R&D | $17.40M | $19.22M | $17.28M | $18.37M | $15.22M | $9.30M |
MARAVAI LIFESCIENCES HOLDINGS, INC. reported annual revenue of $185.74M for fiscal year 2025. That is down 28.3% from $259.19M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $143.14M (FY 2019) to $185.74M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $145.12M |
| $161.77M |
| $151.39M |
| $129.26M |
| $100.06M |
| $94.25M |
| Operating income | -$215.27M | -$235.62M | -$31.65M | $574.22M | $554.64M | $119.90M |
| Income tax | -$4.21M | -$1.86M | $756.11M | $60.81M | $61.52M | $2.88M |
| Net income | -$130.80M | -$144.80M | -$138.40M | $490.70M | $469.30M | $88.97M |
| EPS (diluted) | -$0.90 | -$1.05 | -$0.90 | $1.67 | $1.56 | $2.36 |